LLY Aug 2024 860.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:36AM EDT. Market open.
| Previous close | 53.38 |
| Open | 64.47 |
| Bid | 71.70 |
| Ask | 75.10 |
| Strike | 860.00 |
| Expiry date | 2024-08-09 |
| Day's range | 53.38 - 64.47 |
| Contract range | N/A |
| Volume | |
| Open interest | 5 |
Investor's Business DailyStock Market: S&P 500, Nasdaq Hit Highs As Tesla Soars, Rate-Cut Hopes Rise: Weekly Review
Tesla drove the S&P 500 and Nasdaq to highs, though small caps fell for the week. Cooling economic data raised rate-cut hopes.
ZacksPharma Stock Roundup: FDA Nod to LLY's Kisunla, SNY's Dupixent Gets EU Nod for COPD
Eli Lilly (LLY) wins FDA approval for its Alzheimer's disease drug, Kisunla. (donanemab). Sanofi (SNY) and Regeneron's Dupixent gets approval for COPD in Europe.
ZacksNVO, LLY Slip After Study Links Obesity Drug Use to Vision Loss
A new study led by investigators of a Harvard-affiliated teaching hospital found that Novo Nordisk's (NVO) GLP-1 drugs Ozempic and Wegovy could be linked to rare cases of vision loss.
© 2024 Yahoo. All rights reserved.